Delivery Order SPE2DR25D1202-SPE2DR26F72WB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) under a firm fixed price contract valued at $2,075.73. The award was issued on November 10, 2025, with an ultimate completion date of November 12, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,710.30 for Vemlidy 25 mg tablets (30-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, valued at $4,584.29. This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, issued under a competitive procurement with no set-aside designation. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $8.84K to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on December 2, 2025, with completion expected by December 3, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units at a firm fixed price ceiling value of $7,543.09. This non-set-aside delivery order represents a routine pharmaceutical procurement supporting federal healthcare operations. The contract is scheduled for ultimate completion on May 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,542.33 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-tablet units) on September 19, 2025, with completion scheduled for September 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning the award was made through open competition. The pharmaceutical will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 tablets per unit. This firm fixed-price delivery order, valued at $11,591.64 with an ultimate completion date of November 28, 2025, represents a non-competitive continuation of the company's existing pharmaceutical supply relationship with the federal government. The award was issued without a set-aside designation and will...
- The Defense Logistics Agency awarded a delivery order valued at $6,057.57 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) with a completion date of December 2, 2025. This firm fixed-price contract, awarded December 1, 2025, represents a non-set-aside competitive award to support federal pharmaceutical procurement needs. AmerisourceBergen's Conshohocken, Pennsylvania facility will serve as the place of performance for this delivery order. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,637.91 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count packaging) on November 3, 2025, with completion scheduled for November 4, 2025. This firm fixed-price delivery order represents a direct pharmaceutical procurement from the prime contractor's corporate office located in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting open competition...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, with a contract ceiling value of $2,828.40. This firm fixed-price delivery order, with an ultimate completion date of November 12, 2025, represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F72WBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets in a quantity of 30 units, valued at $37,930.26. This is a firm fixed price, non-set-aside contract with a completion date of December 9, 2025. The award was issued on December 8, 2025, with performance to take place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract represents AmerisourceBergen's continued participation in federal pharmaceutical supply chains as the Defense Logistics Agency plans for future Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards anticipated.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.9k | 12/7/25 |